Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373779

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373779

Global Insulin Pens Market Size, Share, Growth Analysis, By Type(first generation pens and second-generation pens), By Usability(prefilled pens and reusable pens) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Insulin Pens Market size was valued at USD 1.09 Billion in 2021 and is poised to grow from USD 1.16 Billion in 2022 to USD 1.88 Billion by 2030, at a CAGR of 6.26% during the forecast period (2023-2030).

The global insulin pens market has witnessed significant growth in recent years due to the increasing prevalence of diabetes and the growing adoption of insulin pens as a convenient and user-friendly method of insulin delivery. Insulin pens offer advantages such as ease of use, accurate dosing, and portability, making them a preferred choice for diabetic patients. The market is driven by the rising diabetic population worldwide, especially in developing countries, coupled with the growing awareness about the benefits of insulin pens in managing diabetes. Furthermore, technological advancements have led to the development of innovative insulin pens with features like memory function, Bluetooth connectivity, and compatibility with digital platforms for data tracking and analysis. These advancements have enhanced patient convenience and improved treatment outcomes, thereby driving market growth. Despite the positive growth trajectory, the global insulin pens market faces certain challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Insulin Pens Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

The global insulin pens market is segmented on the basis of type, usability, and region. By type, the market is segmented into first generation pens and second-generation pens. By usability, the market is segmented into prefilled pens and reusable pens. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Insulin Pens Market Dynamics

Insulin Pens Market Drivers

Technological Advancements

  • Continuous technological advancements in insulin pen devices, such as Bluetooth connectivity, memory functions, and smart insulin pens, enhance patient experience and improve treatment outcomes. These advancements drive market growth by offering additional features and functionalities to users.

Preference for Self-Administration

  • Insulin pens allow patients to self-administer insulin, reducing the need for healthcare provider assistance and promoting patient independence in managing their diabetes. The preference for self-administration contributes to the increasing adoption of insulin pens.

Insulin Pens Market Restraints

Needle Phobia and Resistance

  • Some individuals may have needle phobia or resistance to self-injection, which can limit the acceptance and use of insulin pens. Needle anxiety or fear of injections may result in reduced compliance and preference for alternative insulin delivery methods.

Regulatory and Safety Considerations

  • Insulin pen manufacturers need to comply with strict regulatory requirements and safety standards to ensure the quality, safety, and effectiveness of their devices. Compliance with regulations and quality control measures can add complexity and cost to the manufacturing process.

Market Trends of the Global Insulin Pens Key

  • Customization and Personalization: There is a growing demand for insulin pens that cater to individual patient needs and preferences. Manufacturers are offering customizable options such as different color choices, dose settings, and even personalized branding. Customizable insulin pens enhance user engagement and satisfaction.
  • Focus on Safety Features: Safety is a crucial aspect of insulin pens, and manufacturers are incorporating various safety features to ensure accurate dosing and minimize the risk of medication errors. Needle safety systems, dose confirmation mechanisms, and audible/visual alerts are among the safety features being introduced in insulin pen devices.
Product Code: SQMIG35B2138

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Insulin Pens Market by Type
    • Market Overview
    • first generation pens and second-generation pens
  • Global Insulin Pens Market by Usability
    • Market Overview
    • prefilled pens and reusable pens
  • Global Insulin Pens Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Novo Nordisk A/S - Denmark
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ypsomed Holding AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • BD (Becton, Dickinson and Company) - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Owen Mumford Ltd - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Haselmeier AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Companion Medical, Inc. - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Biocon Ltd - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Emperra GmbH E-Health Technologies - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bigfoot Biomedical, Inc. - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Diamesco Co., Ltd. - South Korea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • MANNKind Corporation - US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Jiangsu Delfu Medical Device Co., Ltd. - China
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pendiq GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sensile Medical AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Injex Pharma AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Copernicus Sp. z o.o. - Poland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Wockhardt Ltd - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!